Therefore, RIPK1-induced inflammatory response in microglia could potentially play a key role in the pathogenesis of AD that is characterized by chronic inflammation, elevated pro-inflammatory cytokines as well as microglial activation. This evidence concerns the gene RIPK1 and Alzheimer disease.